デフォルト表紙
市場調査レポート
商品コード
1609161

神経学患者モニタリング市場:デバイス、疾患タイプ、エンドユーザー別-2025-2030年の世界予測

Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
神経学患者モニタリング市場:デバイス、疾患タイプ、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経学患者モニタリング市場は、2023年に51億8,000万米ドルと評価され、2024年には55億5,000万米ドルに達すると予測され、CAGR 7.90%で成長し、2030年には88億4,000万米ドルに達すると予測されています。

神経学患者モニタリング市場には、さまざまな生理学的・解剖学的パラメータを評価することで神経学的状態を追跡する技術や機器が含まれます。この市場は、てんかん、外傷性脳損傷、パーキンソン病、脳卒中などの状態を管理するために極めて重要です。神経学患者モニタリングの必要性は、神経疾患の正確な診断と効果的な管理の必要性にあり、リアルタイムでのデータ収集と、患者の転帰を改善するための重要な意思決定を可能にします。アプリケーションは、病院、クリニック、在宅ケアなど多岐にわたり、エンドユーザーには神経科医、ヘルスケア専門家、患者自身が含まれます。主な市場促進要因としては、神経疾患の有病率の増加、モニタリング技術の進歩、神経学的健康に対する意識の高まりなどが挙げられます。さらに、遠隔医療や遠隔患者モニタリングの成長により、特にヘルスケアへのアクセスが限られている地域で潜在的な機会が生まれています。特に、モニタリングシステムにおける予測分析と自動化のための人工知能と機械学習の統合は、急成長の機会を示しています。

主な市場の統計
基準年[2023] 51億8,000万米ドル
予測年[2024] 55億5,000万米ドル
予測年[2030] 88億4,000万米ドル
CAGR(%) 7.90%

しかし、高度なモニタリング機器に関連する高コストや、低資源地域における限られたインフラなどの課題も残っています。また、規制当局の複雑な認可に対応することも、新規参入企業にとって市場参入の障壁となっています。さらに、デジタル・モニタリング・ソリューションにおけるデータ・プライバシーとセキュリティの懸念には、慎重な検討と強固なソリューションが必要です。技術革新に最適な分野としては、費用対効果が高く携帯可能なモニタリングシステムの開発、データ分析機能の強化、幅広い普及に向けたユーザーフレンドリーなインターフェースの改善などが挙げられます。さまざまなセンシング技術を統合したマルチモーダルモニタリングシステムの調査は、市場に大きなメリットをもたらす可能性があります。この市場の性質は競争が激しく、急速に進化しており、新技術の絶え間ない出現と、既存企業と新興企業の両方が参入していることが特徴です。市場機会を活用するために、企業は戦略的パートナーシップに注力し、未開拓市場を開拓し、ユーザー中心の製品開発を優先すべきです。包括的な顧客サポートを重視し、デジタルヘルスの進歩を活用することで、市場のポジショニングをさらに強固なものとし、持続的な成長を促進することができると思われます。

市場力学:急速に進化する神経学患者モニタリング市場の主要市場インサイトを公開

神経学患者モニタリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 低侵襲脳神経外科手術への嗜好の高まり
    • 世界中で増加する神経疾患の負担
    • 神経疾患に対する意識向上プログラムの増加
  • 市場抑制要因
    • 神経外科手術コストの上昇
  • 市場機会
    • 先端技術の統合
    • 有利な償還シナリオ
  • 市場の課題
    • 世界の神経外科医の不足

ポーターのファイブフォース:神経学患者モニタリング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:神経学患者モニタリング市場における外部からの影響の把握

外部マクロ環境要因は、神経学患者モニタリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経学患者モニタリング市場における競合情勢の把握

神経学患者モニタリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経学患者モニタリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経学患者モニタリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経学患者モニタリング市場における成功への道筋を描く

神経学患者モニタリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 低侵襲脳神経外科手術への関心の高まり
      • 世界中で神経疾患の負担が増加
      • 神経疾患に関する啓発プログラムの拡大
    • 抑制要因
      • 脳神経外科手術のコスト高騰
    • 機会
      • 先進技術の統合
      • 有利な償還シナリオ
    • 課題
      • 世界中で脳神経外科医が不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 神経学患者モニタリング市場:デバイス別

  • 脳酸素飽和度計
  • 脳波モニター
  • 頭蓋内圧モニター
  • 磁気共鳴画像(MRI)装置

第7章 神経学患者モニタリング市場:疾患タイプ別

  • てんかん
  • パーキンソン病
  • 睡眠障害
  • 脳卒中と片頭痛
  • 外傷性脳損傷(TBI)

第8章 神経学患者モニタリング市場:エンドユーザー別

  • 外来手術センター
  • 診断センター
  • 病院
  • 神経学センター

第9章 南北アメリカの神経学患者モニタリング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の神経学患者モニタリング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの神経学患者モニタリング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Advanced Brain Monitoring, Inc.
  • Digitimer Ltd.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • General Electric Company
  • Integra LifeSciences Corporation
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic PLC
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • NovaSignal Corporation
  • RAUMEDIC AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG.
図表

LIST OF FIGURES

  • FIGURE 1. NEUROLOGY PATIENT MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROLOGY PATIENT MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROLOGY PATIENT MONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CEREBRAL OXIMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE & MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEUROLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market was valued at USD 5.18 billion in 2023, expected to reach USD 5.55 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 8.84 billion by 2030.

The neurology patient monitoring market encompasses technologies and devices that track neurological conditions by assessing various physiological and anatomical parameters. This market is pivotal for managing conditions such as epilepsy, traumatic brain injuries, Parkinson's disease, and stroke. The necessity for neurology patient monitoring lies in the need for precise diagnosis and effective management of neurological disorders, enabling real-time data collection and critical decision-making for improved patient outcomes. Applications span across hospitals, clinics, and homecare settings, with end-users including neurologists, healthcare professionals, and patients themselves. Key market drivers include the increasing prevalence of neurological disorders, advancements in monitoring technologies, and heightened awareness of neurological health. Furthermore, the growth of telemedicine and remote patient monitoring creates potential opportunities, especially in regions with limited healthcare access. Notably, the integration of artificial intelligence and machine learning for predictive analytics and automation in monitoring systems represents a burgeoning opportunity for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.18 billion
Estimated Year [2024] USD 5.55 billion
Forecast Year [2030] USD 8.84 billion
CAGR (%) 7.90%

However, challenges persist, including high costs associated with advanced monitoring devices and limited infrastructure in low-resource areas. Navigating the complexities of regulatory approvals also poses barriers to market entry for new players. Moreover, data privacy and security concerns in digital monitoring solutions demand careful consideration and robust solutions. The best areas for innovation include developing cost-effective and portable monitoring systems, enhancing data analytics capabilities, and improving user-friendly interfaces for broader adoption. Research into multimodal monitoring systems integrating different sensing technologies could yield significant market advantages. The nature of this market is highly competitive and rapidly evolving, characterized by the continuous emergence of new technologies and the participation of both established players and startups. To capitalize on market opportunities, businesses should focus on strategic partnerships, explore untapped markets, and prioritize user-centric product development. Emphasizing comprehensive customer support and leveraging advancements in digital health could further solidify market positioning and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurology Patient Monitoring Market

The Neurology Patient Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising preference for minimally invasive neurosurgeries
    • Increasing burden of neurological disorders across the globe
    • Growing awareness programs for neurological disorders
  • Market Restraints
    • Elevated cost of neurosurgeries
  • Market Opportunities
    • Integration of advanced technologies
    • Favorable reimbursement scenario
  • Market Challenges
    • Shortage of neurosurgeons across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neurology Patient Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurology Patient Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurology Patient Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurology Patient Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurology Patient Monitoring Market

A detailed market share analysis in the Neurology Patient Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurology Patient Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurology Patient Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurology Patient Monitoring Market

A strategic analysis of the Neurology Patient Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurology Patient Monitoring Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc., Digitimer Ltd., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, General Electric Company, Integra LifeSciences Corporation, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NovaSignal Corporation, RAUMEDIC AG, SOPHYSA SA, and Spiegelberg GmbH & Co. KG..

Market Segmentation & Coverage

This research report categorizes the Neurology Patient Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors, and Magnetic Resonance Imaging (MRI) Devices.
  • Based on Disease Type, market is studied across Epilepsy, Parkinson's Disease, Sleep Disorders, Stroke & Migraine, and Traumatic Brain Injury (TBI).
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Neurology Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference for minimally invasive neurosurgeries
      • 5.1.1.2. Increasing burden of neurological disorders across the globe
      • 5.1.1.3. Growing awareness programs for neurological disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Elevated cost of neurosurgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies
      • 5.1.3.2. Favorable reimbursement scenario
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of neurosurgeons across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurology Patient Monitoring Market, by Device

  • 6.1. Introduction
  • 6.2. Cerebral Oximeters
  • 6.3. Electroencephalography Monitors
  • 6.4. Intracranial Pressure Monitors
  • 6.5. Magnetic Resonance Imaging (MRI) Devices

7. Neurology Patient Monitoring Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Epilepsy
  • 7.3. Parkinson's Disease
  • 7.4. Sleep Disorders
  • 7.5. Stroke & Migraine
  • 7.6. Traumatic Brain Injury (TBI)

8. Neurology Patient Monitoring Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals
  • 8.5. Neurology Centers

9. Americas Neurology Patient Monitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurology Patient Monitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurology Patient Monitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Brain Monitoring, Inc.
  • 2. Digitimer Ltd.
  • 3. Dragerwerk AG & Co. KGaA
  • 4. Edwards Lifesciences Corporation
  • 5. General Electric Company
  • 6. Integra LifeSciences Corporation
  • 7. Koninklijke Philips N.V.
  • 8. Masimo Corporation
  • 9. Medtronic PLC
  • 10. Natus Medical Incorporated
  • 11. Nihon Kohden Corporation
  • 12. NovaSignal Corporation
  • 13. RAUMEDIC AG
  • 14. SOPHYSA SA
  • 15. Spiegelberg GmbH & Co. KG.